524 related articles for article (PubMed ID: 30760613)
1. Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of
Jackson JW; Hancock TJ; Dogra P; Patel R; Arav-Boger R; Williams AD; Kennel SJ; Wall JS; Sparer TE
mSphere; 2019 Feb; 4(1):. PubMed ID: 30760613
[TBL] [Abstract][Full Text] [Related]
2. The D-form of a novel heparan binding peptide decreases cytomegalovirus infection in vivo and in vitro.
Pitt EA; Dogra P; Patel RS; Williams A; Wall JS; Sparer TE
Antiviral Res; 2016 Nov; 135():15-23. PubMed ID: 27678155
[TBL] [Abstract][Full Text] [Related]
3. Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.
Luganini A; Giuliani A; Pirri G; Pizzuto L; Landolfo S; Gribaudo G
Antiviral Res; 2010 Mar; 85(3):532-40. PubMed ID: 20083141
[TBL] [Abstract][Full Text] [Related]
4. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
Neyts J; De Clercq E
Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER
Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323
[TBL] [Abstract][Full Text] [Related]
6. Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus.
Scott GM; Ng HL; Morton CJ; Parker MW; Rawlinson WD
J Gen Virol; 2005 Aug; 86(Pt 8):2141-2151. PubMed ID: 16033961
[TBL] [Abstract][Full Text] [Related]
7. Novel heparan sulfate-binding peptides for blocking herpesvirus entry.
Dogra P; Martin EB; Williams A; Richardson RL; Foster JS; Hackenback N; Kennel SJ; Sparer TE; Wall JS
PLoS One; 2015; 10(5):e0126239. PubMed ID: 25992785
[TBL] [Abstract][Full Text] [Related]
8. The discovery and development of filociclovir for the prevention and treatment of human cytomegalovirus-related disease.
Hussein ITM; Brooks J; Bowlin TL
Antiviral Res; 2020 Apr; 176():104710. PubMed ID: 31940473
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Cytomegalovirus Replication with Extended-Half-Life Synthetic Ozonides.
Wang Y; Mukhopadhyay R; Roy S; Kapoor A; Su YP; Charman SA; Chen G; Wu J; Wang X; Vennerstrom JL; Arav-Boger R
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373792
[TBL] [Abstract][Full Text] [Related]
10. The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo.
Kaptein SJ; Efferth T; Leis M; Rechter S; Auerochs S; Kalmer M; Bruggeman CA; Vink C; Stamminger T; Marschall M
Antiviral Res; 2006 Feb; 69(2):60-9. PubMed ID: 16325931
[TBL] [Abstract][Full Text] [Related]
11. Evasion of a Human Cytomegalovirus Entry Inhibitor with Potent Cysteine Reactivity Is Concomitant with the Utilization of a Heparan Sulfate Proteoglycan-Independent Route of Entry.
Murray MJ; Bonilla-Medrano NI; Lee QL; Oxenford SJ; Angell R; Depledge DP; Reeves MB
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941787
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Human Cytomegalovirus Entry into Host Cells Through a Pleiotropic Small Molecule.
Elste J; Kaltenbach D; Patel VR; Nguyen MT; Sharthiya H; Tandon R; Mehta SK; Volin MV; Fornaro M; Tiwari V; Desai UR
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121406
[TBL] [Abstract][Full Text] [Related]
13. Characterization of M116.1p, a Murine Cytomegalovirus Protein Required for Efficient Infection of Mononuclear Phagocytes.
Ružić T; Juranić Lisnić V; Mahmutefendić Lučin H; Lenac Roviš T; Železnjak J; Cokarić Brdovčak M; Vrbanović A; Oreb D; Kveštak D; Gotovac Jerčić K; Borovečki F; Lučin P; Adler B; Jonjić S; Lisnić B
J Virol; 2022 Jan; 96(2):e0087621. PubMed ID: 34705561
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Mechanism of Action of Low Dose Emetine against Human Cytomegalovirus.
Mukhopadhyay R; Roy S; Venkatadri R; Su YP; Ye W; Barnaeva E; Mathews Griner L; Southall N; Hu X; Wang AQ; Xu X; Dulcey AE; Marugan JJ; Ferrer M; Arav-Boger R
PLoS Pathog; 2016 Jun; 12(6):e1005717. PubMed ID: 27336364
[TBL] [Abstract][Full Text] [Related]
15. The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity.
Luganini A; Mercorelli B; Messa L; Palù G; Gribaudo G; Loregian A
Antiviral Res; 2019 Apr; 164():52-60. PubMed ID: 30738836
[TBL] [Abstract][Full Text] [Related]
16. Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance.
Piret J; Boivin G
Antiviral Res; 2019 Mar; 163():91-105. PubMed ID: 30690043
[TBL] [Abstract][Full Text] [Related]
17. Murine Cytomegalovirus Glycoprotein O Promotes Epithelial Cell Infection
Yunis J; Farrell HE; Bruce K; Lawler C; Wyer O; Davis-Poynter N; Brizić I; Jonjić S; Adler B; Stevenson PG
J Virol; 2019 Feb; 93(3):. PubMed ID: 30404805
[TBL] [Abstract][Full Text] [Related]
18. Human induced pluripotent stem cells are resistant to human cytomegalovirus infection primarily at the attachment level due to the reduced expression of cell-surface heparan sulfate.
Kawasaki H; Hariyama T; Kosugi I; Meguro S; Iwata F; Shimizu K; Magata Y; Iwashita T
J Virol; 2024 Mar; 98(3):e0127823. PubMed ID: 38345384
[TBL] [Abstract][Full Text] [Related]
19. A Live Olfactory Mouse Cytomegalovirus Vaccine, Attenuated for Systemic Spread, Protects against Superinfection.
Farrell HE; Bruce K; Stevenson PG
J Virol; 2021 Oct; 95(21):e0126421. PubMed ID: 34431701
[TBL] [Abstract][Full Text] [Related]
20. Peptide inhibition of human cytomegalovirus infection.
Melnik LI; Garry RF; Morris CA
Virol J; 2011 Feb; 8():76. PubMed ID: 21342525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
